AediCell

AediCell is a private regenerative medicine and wound care company focused on placental tissue-derived biologic products for advanced wound management. The company uses a proprietary manufacturing process to transform human placenta, including amnion/chorion, umbilical cord, and placental disc tissue, into shelf-stable wound care products. Its marketed products include Dermavest and Plurivest, which are used in ulcers, burns, surgical wounds, and other damaged integumentary tissue applications. AediCell emphasizes preservation of extracellular matrix components, cell attachment proteins, cytokines, and growth factors through its processing approach. The company appears to operate as a commercial-stage medical products business rather than a traditional drug-development biotech with a clinical trial pipeline.